A relatively obscure immune cell, the eosinophil, has a dramatic way of defending against pathogens. It rapidly ejects mitochondrial DNA, ensnaring bacteria and hastening their demise (pages 949–953).
References
Rothenberg, M.E. . J. Allergy Clin. Immunol. 113, 11–28; quiz 29 (2004).
Rothenberg, M.E. & Hogan, S.P. Annu. Rev. Immunol. 24, 147–174 (2006).
Yousefi, S. et al. Nat. Med. 949–953 (2008).
Jacobsen, E.A., Taranova, A.G., Lee, N.A. & Lee, J.J. J. Allergy Clin. Immunol. 119, 1313–1320 (2007).
Yang, D. et al. J. Exp. Med. 205, 79–90 (2008).
Jacobsen, E.A. et al. J. Exp. Med. 205, 699–710 (2008).
Walsh, E.R. et al. J. Exp. Med. 205, 1285–1292 (2008).
Mishra, A., Hogan, S.P., Lee, J.J., Foster, P.S. & Rothenberg, M.E. J. Clin. Invest. 103, 1719–1727 (1999).
Brinkmann, V. et al. Science 303, 1532–1535 (2004).
Buchanan, J.T. et al. Curr. Biol. 16, 396–400 (2006).
Fuchs, T.A. et al. J. Cell Biol. 176, 231–241 (2007).
Gray, M.W., Burger, G. & Lang, B.F. Science 283, 1476–1481 (1999).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
M.E.R. is associated with the following companies that are pursuing drugs that target gastrointestinal eosinophils: Ception Therapeutics (consultant and stock owner), Novartis (consultant) and Merck (consultant).
Rights and permissions
About this article
Cite this article
Nizet, V., Rothenberg, M. Mitochondrial missile defense. Nat Med 14, 910–912 (2008). https://doi.org/10.1038/nm0908-910
Issue Date:
DOI: https://doi.org/10.1038/nm0908-910
- Springer Nature America, Inc.
This article is cited by
-
The Eosinophil in Infection
Clinical Reviews in Allergy & Immunology (2016)
-
Innate immunity turned inside-out: antimicrobial defense by phagocyte extracellular traps
Journal of Molecular Medicine (2009)